
Angel Amado Lazo Jr. MD FACP
Alpha Hospital Partners, Senior Vice President and Chief Scientific Officer
Join to View Full Profile
95 Greene StJersey City, NJ 07302
Phone+1 201-499-8730
Dr. Lazo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Angel Lazo Jr. is an Internal Medicine specialist based in Jersey City and Union City, NJ. His medical training includes two residencies in Internal Medicine, one at the Rutgers Health/New Jersey Medical School from 1997 to 1998 and another at the Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital from 1997 to 2000. Dr. Lazo initially graduated from the Universidad Central del Este Facultad de Medicina in 1984. Graduated valedictorian from Jersey City Medical Center, affiliate of Mount Sinai School of Medicine, New York.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1997 - 2000
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1997 - 1998
- Universidad Central del Este Facultad de MedicinaClass of 1984
Certifications & Licensure
- NJ State Medical License 2000 - 2025
- FL State Medical License 2000 - 2018
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Valedictorian Mount Sinai School of Medicine Residency program /Jersey City Medical Center, 2000
Publications & Presentations
PubMed
- 465 citationsExosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.Vikram Sengupta, Sascha Sengupta, Angel Lazo, Peter Woods, Anna Nolan
Stem Cells and Development. 2020-06-11
Committees
- chairman of the Covid Board, Former Direct Biologics key Opinion Leader
Research History
- Chief scientific officerResearch in the use of biologics in acute adult respiratory distress syndrome and ischemia reperfusion injury.
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: